You bring up an interesting point. I think the evidence presented to date as well as TEVA's loose relationship with the truth leads me to think that TEVA will never get approved. However, if they did get approved , I imagine it would be fairly easy for MNTA to analyze TEVA's formulation. Could MNTA then: a) Sue TEVA for patent violations? b) Sue the FDA for violating its own rules if they felt TEVA's version did not truly meet the "sameness" test? This all theoretical of course but I thought it was an interesting scenario.